In addition, established cancer genes like Lmo2, RhoH, Trim33, Mll, and Hspca (Futreal et al., 2004) are candidate target genes of less frequently mutated CISs, indicating that lower ranked CISs (carrying 4–5 insertions) may represent bona fide cancer genes. The gene discussed is LMO2; the disease is cancer.